Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus & Other Hospital Infections
Staphylococcal Infections
About this trial
This is an interventional prevention trial for Staphylococcal Infections focused on measuring Methicillin resistance, Infection control, Staphylococcus aureus, Cross infection, Epidemiology, Chlorhexidine
Eligibility Criteria
Inclusion Criteria:
- All patients admitted to the medical intensive care unit (ICU) are eligible for inclusion
Exclusion Criteria:
- Patient refusal
- Contraindication to nasal swabbing (arm 1)
- Allergy/sensitivity to chlorhexidine gluconate (CHG) (arm 2)
Sites / Locations
- Christiana Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
1
2
Active surveillance cultures (ASC) (via nasal swabs) will be performed for all patients admitted to the medical intensive care unit (ICU) during the designated study period. All patients will be placed in contact isolation until nasal swabs return negative; otherwise will remain in isolation.
Chlorhexidine gluconate (CHG) cloths will be used to bathe patients daily instead of standard soap and water. Active surveillance cultures (ASC) will also be used in this arm, but results will be blinded and not used to determine whether patients should be in contact isolation.